Shuttle Pharmaceuticals Holdings (SHPH) Change in Acquisitions & Divestments (2023 - 2024)

Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Change in Acquisitions & Divestments came in at $1.7 million in Q3 2024, up 41.6% quarter-over-quarter from $1.2 million in Q2 2024.

Shuttle Pharmaceuticals Holdings (SHPH) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $1.7 million for Q3 2024.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $1.7 million in Q3 2024; TTM through Dec 2024 was $3.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $3.0 million, up 1475.0% from the prior year.
  • Change in Acquisitions & Divestments grew to $1.7 million in Q3 2024 per SHPH's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $1.7 million in Q3 2024 and bottomed at $107895.0 in Q4 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.97 Bn 87.10 Bn -
2 Teva Pharmaceutical Industries 35.95 Bn 32.21 Bn 1.97 Bn
3 Zoetis 32.26 Bn 30.32 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn
5 United Therapeutics 23.15 Bn 21.00 Bn 648.10 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn -
7 Viatris 20.27 Bn 18.46 Bn 1.16 Bn
8 Neurocrine Biosciences 17.86 Bn 16.55 Bn 800.70 Mn
9 Elanco Animal Health 12.66 Bn 12.23 Bn 785.00 Mn
10 Shuttle Pharmaceuticals Holdings 1.41 Mn 1.41 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 1.66 Mn
Sep 30, 2024 1.66 Mn
Jun 30, 2024 1.18 Mn
Jun 30, 2024 1.18 Mn
Mar 31, 2024 120,000.00
Mar 31, 2024 120,000.00
Dec 31, 2023 107,895.00
Dec 31, 2023 107,895.00